Treatment of Orthostatic Hypotension in Autonomic Failure
Public ClinicalTrials.gov record NCT00223691. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Evaluation and Treatment of Autonomic Failure.
Study identification
- NCT ID
- NCT00223691
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Vanderbilt University
- Other
- Enrollment
- 389 participants
Conditions and interventions
Conditions
Interventions
- Acarbose Drug
- Acetazolamide Drug
- Atomoxetine Drug
- Bovril Dietary Supplement
- Carbidopa/levodopa Drug
- Celecoxib Drug
- Diphenhydramine Hydrochloride Drug
- Ergotamine/ Caffeine Drug
- Ibuprofen Drug
- Indomethacin Drug
- Inflatable abdominal binder Device
- Methylphenidate Drug
- Midodrine HCl Drug
- Modafinil Drug
- Octreotide Drug
- Oxymetazoline 0.05% nasal solution Drug
- Pseudoephedrine Drug
- Pyridostigmine Bromide Drug
- Ranitidine HCL Drug
- Rivastigmine tartrate Drug
- Tranylcypromine Drug
- Yohimbine Drug
- inflatable abdominal binder (sham) Device
- placebo Drug
- water intake Other
Drug · Dietary Supplement · Device + 1 more
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2002
- Primary completion
- Dec 31, 2016
- Completion
- Dec 31, 2016
- Last update posted
- Jan 17, 2017
2002 – 2017
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanderbilt University | Nashville | Tennessee | 37232 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00223691, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 17, 2017 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00223691 live on ClinicalTrials.gov.